Mloptic Corp. (688502.SH) controlling shareholder and actual controller intend to inquire about transferring 3% of the shares.
Maolai Optics (688502.SH) released a shareholder inquiry and transfer plan, and the shareholders who intend to participate in the shareholder inquiry and transfer before the company's initial public offering are Nanjing Maolai Holdings Co., Ltd. (hereinafter referred to as "Maolai Holdings"), Fan Yi, and Fan Hao (the three shareholders are collectively referred to as the "transferor"). The transferors intend to transfer a total of 1.584 million shares, accounting for 3.00% of Maolai Optics' total share capital.
Mloptic Corp. (688502.SH) has released a shareholder inquiry transfer plan. The shareholders who intend to participate in the pre-IPO shareholder inquiry transfer of the company are Nanjing Maolai Holdings Limited (hereinafter referred to as "Maolai Holdings"), Fan Yi, and Fan Hao (hereinafter referred to as "the transferors"). The transferors intend to transfer a total of 1.584 million shares, accounting for 3.00% of Mloptic Corp.'s total share capital.
Maolai Holdings, as one of the transferors in this inquiry transfer, is a controlling shareholder of the company, holding more than 5% of the shares. Fan Yi and Fan Hao, the other transferors in this inquiry transfer, collectively directly hold 6.82% of the company's shares, and indirectly control 59.47% of the company's shares through Maolai Holdings. Therefore, Fan Yi and Fan Hao collectively directly and indirectly control 66.29% of the company's shares.
Related Articles

Zhejiang Meili High Technology (300611.SZ) plans to repurchase company shares with an amount ranging from 40 million to 70 million yuan.

IMOTIONTECH (01274) spent 1.77 million Hong Kong dollars to repurchase 385,500 shares on May 22nd.

CSPC PHARMA (01093): Ulinastatin Injection Obtains Approval from National Medical Products Administration for Market Launch.
Zhejiang Meili High Technology (300611.SZ) plans to repurchase company shares with an amount ranging from 40 million to 70 million yuan.

IMOTIONTECH (01274) spent 1.77 million Hong Kong dollars to repurchase 385,500 shares on May 22nd.

CSPC PHARMA (01093): Ulinastatin Injection Obtains Approval from National Medical Products Administration for Market Launch.






